CodeRunner

Lipid Nanoparticles (LNPs) protect payloads like mRNA/siRNA and enable cytosolic delivery. Creative Biolabs offers end-to-end LNP formulation/optimization for nucleic acids and small molecules, focusing on precision delivery and extrahepatic targeting for cancer, infectious diseases, and rare genetic disorders.

It leverages ML to speed up lead selection, uses targeted surface modification, conquers the IVIVC gap, ensures superior stability/efficacy, minimizes toxicity and risk, shortens development cycles and time-to-market, solving poor lab-animal study correlation and non-liver targeting issues.